2.1(top 20%)
impact factor
3.2K(top 10%)
51.9K(top 10%)
79(top 10%)
2.2(top 20%)
extended IF
all documents
doc citations
138(top 5%)

Top Articles

1Random-effects model for meta-analysis of clinical trials: An updateContemporary Clinical Trials20071,801
2Meta-analysis in clinical trials revisitedContemporary Clinical Trials20151,745
3Design and analysis of stepped wedge cluster randomized trialsContemporary Clinical Trials20071,010
4Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study — A large observational study of the determinants of fracture in older menContemporary Clinical Trials2005670
5Overview of recruitment for the osteoporotic fractures in men study (MrOS)Contemporary Clinical Trials2005506
6The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular diseaseContemporary Clinical Trials2012477
7Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity modelContemporary Clinical Trials2015440
8The use of unequal randomisation ratios in clinical trials: A reviewContemporary Clinical Trials2006269
9Pharmaceutical company funding and its consequences: A qualitative systematic reviewContemporary Clinical Trials2008253
10The quality of randomized trial reporting in leading medical journals since the revised CONSORT statementContemporary Clinical Trials2005226
11The effectiveness and ineffectiveness of complex behavioral interventions: Impact of treatment fidelityContemporary Clinical Trials2014215
12Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trialContemporary Clinical Trials2013212
13Are propensity scores really superior to standard multivariable analysis?Contemporary Clinical Trials2011206
14Strategies addressing barriers to clinical trial enrollment of underrepresented populations: A systematic reviewContemporary Clinical Trials2014206
15TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: A meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patientsContemporary Clinical Trials2012190
16Clinical trials recruitment planning: A proposed framework from the Clinical Trials Transformation InitiativeContemporary Clinical Trials2018186
17Comparison of methods for estimating the intraclass correlation coefficient for binary responses in cancer prevention cluster randomized trialsContemporary Clinical Trials2012184
18Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study designContemporary Clinical Trials2016178
19Advances in the meta-analysis of heterogeneous clinical trials II: The quality effects modelContemporary Clinical Trials2015171
20Design of the Trial of Activity in Adolescent Girls (TAAG)Contemporary Clinical Trials2005167
21The Ginkgo Evaluation of Memory (GEM) study: Design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementiaContemporary Clinical Trials2006164
22Recruitment of minority and underserved populations in the United States: The centers for population health and health disparities experienceContemporary Clinical Trials2008164
23Inclusion of patient-reported outcome measures in registered clinical trials: Evidence from ClinicalTrials.gov (2007–2013)Contemporary Clinical Trials2015162
24A systematic review of the factors influencing African Americans' participation in cancer clinical trialsContemporary Clinical Trials2013160
25More than the money: A review of the literature examining healthy volunteer motivationsContemporary Clinical Trials2011154
26Can regional analgesia reduce the risk of recurrence after breast cancer?Contemporary Clinical Trials2008149
27The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): Design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancerContemporary Clinical Trials2009146
28Performance of five two-sample location tests for skewed distributions with unequal variancesContemporary Clinical Trials2009141
29Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial designContemporary Clinical Trials2009140
30The Vitamin D Antenatal Asthma Reduction Trial (VDAART): Rationale, design, and methods of a randomized, controlled trial of vitamin D supplementation in pregnancy for the primary prevention of asthma and allergies in childrenContemporary Clinical Trials2014139
31Pilot and feasibility studies: Is there a difference from each other and from a randomised controlled trial?Contemporary Clinical Trials2014139
32Recruitment and retention strategies in longitudinal clinical studies with low-income populationsContemporary Clinical Trials2011137
33The lifestyle interventions and independence for elders (LIFE) pilot study: Design and methodsContemporary Clinical Trials2005129
34ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumoursContemporary Clinical Trials2016129
35Reporting of harms in randomized controlled trials of psychological interventions for mental and behavioral disorders: A review of current practiceContemporary Clinical Trials2014127
36Review of randomised trials using the post-randomised consent (Zelen's) designContemporary Clinical Trials2006125
37Detecting a clinically meaningful change in tic severity in Tourette syndrome: A comparison of three methodsContemporary Clinical Trials2013124
38Using e-technologies in clinical trialsContemporary Clinical Trials2015124
39Using instrumented paper diaries to document self-monitoring patterns in weight lossContemporary Clinical Trials2008122
40The use of patient-reported outcomes instruments in registered clinical trials: Evidence from ClinicalTrials.govContemporary Clinical Trials2009122
41Overfitting in prediction models – Is it a problem only in high dimensions?Contemporary Clinical Trials2013122
42Do “placebo responders” exist?Contemporary Clinical Trials2008118
43Physical activity and lymphedema (the PAL trial): Assessing the safety of progressive strength training in breast cancer survivorsContemporary Clinical Trials2009116
44Recruitment and retention strategies in clinical studies with low-income and minority populations: Progress from 2004–2014Contemporary Clinical Trials2015115
45Wearable activity monitors in oncology trials: Current use of an emerging technologyContemporary Clinical Trials2018115
46An analysis of U.S. practices of paying research participantsContemporary Clinical Trials2005113
47Comparison of paper-based and electronic data collection process in clinical trials: Costs simulation studyContemporary Clinical Trials2009113
48Early anti-pseudomonal acquisition in young patients with cystic fibrosis: Rationale and design of the EPIC clinical trial and observational study,Contemporary Clinical Trials2009110
49SMART trial: A randomized clinical trial of self-monitoring in behavioral weight management-design and baseline findingsContemporary Clinical Trials2009109
50The CALERIE Study: Design and methods of an innovative 25% caloric restriction interventionContemporary Clinical Trials2011109